The consistency is a great testament to the process stability and I did like the mention of additional test work with a potential off-take customer
(Japanese thank goodness)
Was wondering if some additional SX phases to strip out the Ca/Na/K//Mg might be in the works to get the purity levels up for those new HPA use cases.
I guesstimated the SX phase might only be a 1-2K of the overall OPEX, so bit of room to move if the product price point increases (e.g. 50K/t)
Although might be hard to get those low atomic weight, lower valency elements out of the solvents selectively.
IMHO A4N is really starting to look like the front runner here, it already was on CAPEX/OPEX and process simplicity, but now other evidence is starting to pop up. DFS and funding next steps.
- Forums
- ASX - By Stock
- Ann: Company Activities Update
A4N
alpha hpa limited
Add to My Watchlist
0.55%
!
90.0¢

The consistency is a great testament to the process stability...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
90.0¢ |
Change
-0.005(0.55%) |
Mkt cap ! $1.023B |
Open | High | Low | Value | Volume |
89.0¢ | 91.5¢ | 89.0¢ | $842.4K | 933.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23448 | 87.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
90.5¢ | 35014 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 23448 | 0.870 |
2 | 1755 | 0.860 |
1 | 1200 | 0.855 |
1 | 1300 | 0.850 |
1 | 500 | 0.840 |
Price($) | Vol. | No. |
---|---|---|
0.905 | 35014 | 1 |
0.915 | 1708 | 1 |
0.920 | 59484 | 4 |
0.935 | 5000 | 1 |
0.940 | 45000 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
A4N (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online